Improving patient outcomes in pulmonary hypertension.

نویسندگان

  • Nazzareno Galiè
  • Vallerie V McLaughlin
  • Lewis J Rubin
  • Gérald Simonneau
چکیده

Affiliations: Dept of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, Bologna, Italy. Dept of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA. Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA, USA. Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Recent Trends in the Management of Pulmonary Hypertension

Context. Pulmonary hypertension is a common clinical problem encountered in day-to-day practice. Drug therapy forms the backbone of management and appropriate drug selection is based upon the underlying causes. The options available are widening with availability of newer therapeutic agents and thus it becomes necessary to be updated with the recent developments. Objective. To review the existi...

متن کامل

گزارش یک مورد از هیپرتانسیون ترومبوآمبولیک پولمونر در جریان سندروم آنتی فسفولیپید اولیه

While pulmonary thromboembolism is common, thromboembolic pulmonary hypertension is very rare. The present case is a 35 year old woman with chronic thromboembolic pulmonary hypertension, who presented with severe dyspnea and leg edema, following an earlier thrombotic event of 10 years earlier, after her her second childbearing. She also had a history of the first childbearing complicated with c...

متن کامل

Pulmonary Hypertension Registry: a 10-Year Experience

Background: Pulmonary Arterial Hypertension (PAH), a fatal orphan disease, is defined as increased mean Pulmonary Arterial Pressure (mPAP) above 25 mm/Hg, Pulmonary Capillary Wedge Pressure (PCWP) below 15 mm/Hg, and pulmonary vascular Resistance over 3 Wood Unit (WU). Although Pulmonary Hypertension (PH) is a relatively prevalent disease, the idiopathic form (iPAH) is a rare disease with a pre...

متن کامل

Reversible Pulmonary Hypertension in an Infant Treated with Diazoxide

Background: Diazoxide is the main therapeutic agent for congenital hyperinsulinism. The drug is generally well tolerated; however, in this report severe adverse effects including heart failure (HF) and pulmonary hypertension (PH) in an infant are reported.Case report: A sixteen-day male infant with persistent hypoglycemia and with diagnosis of congenital hyperinsulinism underwent near total pan...

متن کامل

Application of centrifugal pump in right ventricular failure due to pulmonary artery hypertension. (A case report)

Background: It has not been yet developed a ost suitable method to treat right ventricular failure due to pulmonar artery hypertention resulted from ventricular arrhythia. Though some case reports about patients ready to heart transplant using left assist device or biventral assist device as bridge have been published in Journals, but nocase concerning application of centrifugal pump for treatm...

متن کامل

گزارش یک موردOndines curse

ABSTRACT Pulmonary hypertension is one of the causes of cyanosis in children. Pulmonary hypertention may be primary or secondary. Etiology of secondery PH are variable and one of them is pulmonary ventilation abnormality. One of the rare causes of secondary PH is congenital central hypoventilation syndrome or ondines curse. The patient was 6 years old boy presented with easy fati...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • European respiratory review : an official journal of the European Respiratory Society

دوره 24 138  شماره 

صفحات  -

تاریخ انتشار 2015